Fatty Liver Disease: Why It Matters and What Actually Helps

Liver health

Patient education · Reviewed by the treating clinician · Last reviewed January 2026

Fatty liver is one of the most common findings on an abdominal ultrasound in India today. It is also one of the most misunderstood: some people are told it is nothing to worry about, others are frightened into believing they are close to liver failure. The truth sits between the two, and it depends almost entirely on how much scarring — if any — has already developed.

What fatty liver actually is

Fat cells accumulate inside liver cells. If enough of them do, the liver appears bright (“echogenic”) on ultrasound, and the condition is called hepatic steatosis, or fatty liver. It becomes a problem when the fat is accompanied by inflammation and injury to the liver cells, which over years can lead to scarring.

The terminology has changed recently, and it is worth knowing both sets of names:

• NAFLD — non-alcoholic fatty liver disease. The older, still widely used term.
• MAFLD — metabolic-associated fatty liver disease.
• MASLD — metabolic dysfunction-associated steatotic liver disease. The current preferred term, because it links the condition to metabolic health rather than defining it by what it is not.
• MASH — fatty liver with active inflammation and cell injury. This is the form that matters most.

Why it has become so common

Fatty liver tracks closely with the cluster of conditions doctors call metabolic syndrome: excess weight around the abdomen, type 2 diabetes or prediabetes, high blood pressure, and abnormal cholesterol or triglycerides. As these have become more common in India — including in people who are not particularly overweight — so has fatty liver. There is also a genuine genetic contribution: fatty liver runs in families, and some people develop it with relatively modest metabolic risk factors.

The three grades — and what they do not tell you

Ultrasound reports often say “grade 1”, “grade 2” or “grade 3” fatty liver. These grades describe roughly how much fat is visible on the scan. They do not tell you whether there is inflammation or scarring, and it is inflammation and scarring — not the amount of fat — that determine the long-term risk. It is entirely possible to have grade 3 fat with a healthy liver, and grade 1 fat with significant fibrosis.

How the risk is actually assessed

1. Blood tests. Liver enzymes (ALT, AST, GGT) may be normal or raised. Platelet count, albumin, bilirubin and INR help assess function. Fasting sugar, HbA1c and a lipid profile identify the metabolic component. Scores such as FIB-4 estimate fibrosis risk.
2. FibroScan (transient elastography). The key test. It measures liver stiffness in kilopascals, which reflects fibrosis, and also estimates liver fat. It is painless, takes about ten minutes, and can be repeated to show whether the liver is improving. See FibroScan and liver assessment.
3. Excluding other causes. Alcohol intake, hepatitis B and C, medications, thyroid disease and autoimmune conditions should be considered, because fatty liver is often present alongside, or instead of, something else.
4. Liver biopsy. Rarely needed now. Reserved for cases where non-invasive tests leave genuine uncertainty.

What actually helps — and what does not

This is where much online advice is either vague or unrealistic. In order of impact:

• Gradual weight loss of 7–10% of body weight, if you are overweight. The most effective intervention, with the clearest evidence. Aim for roughly 0.5–1 kg per week; losing weight too fast is counterproductive.
• Reducing refined carbohydrates and added sugar. Sweetened drinks, fruit juice, sweets, white bread and refined snacks drive fat deposition in the liver. Reducing them often shows measurable benefit.
• Controlling diabetes and blood pressure. Good glycaemic control alone improves liver fat. Some diabetes medicines have additional liver benefit — a discussion to have with your treating doctor.
• Physical activity. Around 150 minutes per week of moderate activity, including some resistance work, helps even before significant weight loss occurs.
• Complete avoidance of alcohol. Where fatty liver is present, alcohol adds a second injury on top of the first, and the effect is not linear.
• Reviewing your medicines. Some medicines and some herbal preparations can contribute to liver injury. Tell your doctor everything you take.

What does not help

• Liver “tonics” and detox products. No evidence they reverse fatty liver, and some herbal products cause liver injury themselves.
• Cutting out all fat. Fat is not the driver; excess energy and refined carbohydrate are.
• Extreme crash diets. Rapid weight loss can worsen liver inflammation in some people.
• Doing nothing because the enzymes are normal. A significant minority of people with advanced fibrosis have normal liver enzymes. Normal enzymes are reassuring, not conclusive.

Can fatty liver be reversed?

Early fatty liver — fat without significant fibrosis — can improve substantially, and in many people the ultrasound appearance returns to normal with sustained weight loss and metabolic control. Established fibrosis is less likely to reverse fully, but its progression can be slowed or halted. This is why the assessment matters: it tells you which situation you are in, and therefore how aggressively to act and how closely to be monitored.

How often should it be monitored?

If there is simply fat with no fibrosis, an annual review with blood tests is usually enough, with FibroScan repeated if your weight or metabolic control changes. If fibrosis is present, monitoring is closer, usually every six to twelve months, and if advanced fibrosis or cirrhosis is found, six-monthly ultrasound surveillance for liver cancer becomes part of routine care. Your own schedule should be written down for you at your visit.

When to see a specialist

• Fatty liver found on ultrasound, especially with diabetes, high blood pressure or abnormal lipids.
• Persistently raised liver enzymes (ALT, AST or GGT) without a clear explanation.
• A FIB-4 score or other non-invasive marker suggesting fibrosis.
• A FibroScan result showing significant stiffness.
• Fatty liver with a family history of cirrhosis or liver cancer, or alongside regular alcohol use.